Momordica charantia maintains normal glucose levels and lipid profiles and prevents oxidative stress in diabetic rats subjected to chronic sucrose load

Journal of Medicinal Food

Volumn 13, Issue 3, 2010, Pages 520-527

  Chaturvedi, Padmaja ^a   George, Saramma ^a  

^a BOTSWANA COLLEGE OF AGRICULTURE   (Botswana)

Author keywords

bitter gourd; diabetes mellitus; glucose; lipid profile; Momordica charantia; oxidative stress

Indexed keywords

GLUCOSE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; MOMORDICA CHARANTIA EXTRACT; SUCROSE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN RESISTANCE; MOMORDICA CHARANTIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MOMORDICA CHARANTIA; OXIDATIVE STRESS; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; SUCROSE; TRIGLYCERIDES;

MOMORDICA CHARANTIA; RATTUS;

EID: 77953750796     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2009.0151     Document Type: Article

References (49)

1. Shepherd J: Dyslipidaemia in diabetic patients: time for a rethink. Diabetes Obes Metab 2007;9:609-616.
2. Peerapatdit T, Likidlilid A, Patchanans N, Somkasterin A: Antioxidant status and lipid peroxidation endproducts in patients of type 1 diabetes mellitus. J Med Assoc Thai 2006;89(Suppl 5): S141-S146.
3. Nikkila EA, Hormila P: Serum lipids and lipoproteins in insulin treated diabetes. Diabetes 1978;27:1078-1086.
4. Reusch JE, Draznin BB: Atherosclerosis in diabetes and insulin resistance. Diabetes Obes Metab 2007;9:455-463.
5. Yamgishi S, Matsui T, Ueda S, Nakamura K, Imaizumi T: Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes. Cardiovasc Hematol Agents Med Chem 2007;5:236-240.
6. Thomas JE, Foody JM: The pathophysiology of cardiovascular disease in diabetes mellitus and the future of therapy. J Cardiometab Syndr 2007;2:108-113.
7. Gleeson M, Connaughton V, Arneson LS: Induction of hyperglycaemia in zebra fish (Danio rerio) leads to morphological changes in the retina. Acta Diabetol 2007;44:157-163.
8. Wolf G, Muller N, Mandecka A, Muller UA: Association of diabetic retinopathy and renal function in patients with types 1 and 2 diabetes mellitus. Clin Nephrol 2007;68:81-86.
9. Peerapatdit T, Patchanans N, Likidlilid A, Poldee S, Sriratnassathavorn C: Plasma lipid peroxidation and antioxidant nutrients in type 2 diabetes patients. J Med Assoc Thai 2006;89 (Suppl 5):S147-S155. (Pubitemid 46193144)
10. Kim HJ, Kurup JV: Non enzymatic glycosylation of human plasma low density lipoprotein. Evidence for in vitro and in vivo glycosylation. Metabolism 1982;31:348-353.
11. Wadham C, Parker A, Wang L, Xia P: High glucose attenuates protein S-nitrosylation in endothelial cells: role of oxidative stress. Diabetes 2007;56:2715-2721.
12. Robertson R, Zhou H, Zhang T, Harmon JS: Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in Type 2-diabetes. Cell Biochem Biophys 2007;48:139-146.
13. Gonen B, Baenziger J, Schonfield G, Jacobson D, Farrar P: Nonenzymatic glycosylation of low density lipoproteins in vitro. Effects on cell interactive properties. Diabetes 1981;30:875-878.
14. Basch E, Gabardi S, Ulbricht C: Bitter melon (Momordica charantia): a review of efficacy and safety. Am J Health Syst Pharm 2003;60:356-359.
15. Nafisa PC, Fernandes, Chkradhar VL, Vandana SP, Suresh RN: An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract. BMC Complement Altern Med 2007;7:29.
16. Chaturvedi P, George S, Miliganyo M, Tripathi YB: Effect of M. charantia on lipid profile and oral glucose tolerance in diabetic rats. Phytother Res 2004;18:954-956.
17. Senanayake GV, Maruyama, Sakono M, Fukuda N, Morishita T, Yukizaki C, Kawano M, Ohta H: The effects of bitter melon (Momordica charantia) extracts on serum and liver lipid parameters in hamsters fed cholesterol-free and cholesterolenriched diets. J Nutr Sci Vitaminol 2004;50:253-257.
18. Chaturvedi P: Role of Momordica charantia in maintaining the normal levels of lipids and glucose in diabetic rats fed a high-fat and low-carbohydrate diet. Br J Biomed Sci 2005;62:124-126.
19. Matsuur H, Asakawa C, Kurimoto M, Mizutani J: Alphaglucosidase inhibitor from the seeds of balsam peer (Momordica charantia) and the fruit bodies of Grifola frondosa. Biosci Biotechnol Biochem 2002;66:1576-1578.
20. Kumar Shetty A, Suresh Kumar G, Veeraya Salimath P: Bitter gourd (Momordica charantia) modulates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats. Mol Nutr Food Res 2005;49:791-796.
21. Sridhar MG, Vinayagamoorthi R, Arul Suyabunathan V, Bobby Z, Selvraj N: Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats. Br J Nutr 2008;99:806-812.
22. Chaturvedi P, Akala H: Thyrogenic responses of Momordica charantia. J Applied Zool Res 2003;14:191-194.
23. Laureen LYC, Qixuan C, Adi GGG, Emily KYL, Edmund TSL: Reduced adiposity in bitter melon (Momordica charantia) fed rats is associated with increased lipid oxidation enzyme activities and uncoupling protein expression. J Nutr 2005;135:2517-2523.
24. Wong CM, NG TB, Yeung HW: Screening of Trichosanthes kirilowi, Momordica charantia and Cucurbita maxima for compound with antilypolytic activity. J Ethnopharmacol 1985;13: 312-332.
25. Tan MJ, Ye JM, Turner N, Honen-Behrens C, Ke CQ, Tang CP, Chen T, Weiss HC, Gesing ER, Rowland A, James DE, Ye Y: Antidiabetic activities of triterpenoids isolated from bitter melon associated with the activation of AMPK pathway. Chem Biol 2008;15:263-273.
26. Vikrant V, Grover JK, Tendon N, Rathi SS, Gupta N: Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats. J Ethnopharmacol 2001;76:139-143.
27. Chandra A, Mahdi A, Singh RK, Mahdi F, Chander R: Effect of Indian herbal hypoglycaemic agents on antioxidant capacity and trace element content in diabetic rats. J Med Food 2008;11:506-512.
28. Sathishekar D, Subramanian S: Antioxidant properties of Momordica charantia (bitter gourd) seeds on streptozotocin induced diabetic rats. Asia Pac J Clin Nutr 2005;14:153-158. (Pubitemid 40769784)
29. Kim JY, Nolte LA, Hansen PA, Han DH, Kawanak K, Holloszy JO: Insulin resistance of muscle glucose transport in male and female rats fed a high sucrose diet. Am J Physiol Regul Integr Comp Physiol 1999;276:R665-R672.
30. Storlien LH, Kraegen EW, Jenkins AB, Chisholm DJ: Effects of sucrose vs starch diets on in vivo insulin action, thermogenesis, and obesity. Am J Clin Nutr 1988;47:420-427.
31. Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P, Brand-Miller JC: Glycemic index, glycemic load, and chronic disease risk-a meta analysis of observational studies. Am J Clin Nutr 2008;87:627-637.
32. Mizokami H, Wada R, Koyama M, Takeo T, Suga S, Wakimi M, Yagihashi S: Augmented B-cell loss and mitochondrial abnormalities in sucrose fed GK rats. Virchows Arch 2008;452:383-392.
33. Kawamura M, Heinecke JW, Chait A: Pathophysiological concentration of glucose promotes oxidative modification of low density lipoprotein by superoxidase dependent pathway. J Clin Invest 1994;94:771-778.
34. Papachristodoulou D, Heath H, Kang SS: The development of retinopathy in sucrose fed and streptozotocin-diabetic rats. Diabetologia 1976;12:367-374.
35. Yanko L, Rosenmann E, Cohen AM: A correlative study on the occurrence of retinopathy and nephropathy in sucrose fed diabetic rats. Acta Diabetol 2007;12:52-65.
36. Cao D, Lu H, Lewis TL, Li L: Intake of sucrose sweetned water induces insulin resistance and exacerbates memory deficits and amyloidoses in a transgenic mouse model of Alzheimer disease. J Biol Chem 2007;282:36275-36282.
37. Sushmakumari S, Jaydeep A, Kumar JS, Manon VP: Effect of carnitine on malonyldialdehyde, taurine and glutathione levels in heart of rats subjected to myocardial stress by isoprotenol. Indian J Exp Biol 1989;27:134-137.
38. Ellman GC: Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
39. Bucala R: Site specific modification of apolipoprotein B by advanced glycosylation end-products: implications for lipoprotein clearance and artherogenesis. Nephrol Dial Transplant 1996;11 (Suppl 5):17-19.
40. Witzum J L, Mahoney EM, Branks MJ: Non enzymatic glycosylation of low density lipoprotein alters its biologic activity. Diabetes 1982; 31:283-291.
41. Nerukar PV, Lee YK, Motsue M, Adeli K, Nerukar VR: Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase. Br J Nutr 2008;100:751-759.
42. Miura T, Itoh C, Iwamoto N, Kato M, Kawai M, Park SR, Suzuki I: Hypoglycemic activity of the fruit of Momordica charantia in type 2 diabetic mice. J Nut Sci Vitaminol 2001;47:340-344.
43. Roffey BW, Atwal AS, Johns T, Kubow S: Water extracts from Momordica charantia increase glucose uptake and adiponectin secretion from adipocytes in 3T3-L1 adipose cells. J Ethnopharmacol 2007;112:77-84.
44. Winder WW, Hardie DG: AMP activated protein kinase, a metabolic master switch: possible role in type 2 diabetes. Am J Physiol 1999;277:1-10.
45. Weinstein S, Watts J, Harber R: Thyroid hormone increases muscle=fat glucose transporter gene expression in rat skeletal muscle. Endocrinology 1991;129:455-464.
46. Weinstein S, OBoyle E, Harber R: Thyroid hormone increases basal and insulin stimulated glucose transport in skeletal muscle. Diabetes 1994;43:1185-1189.
47. Yaturu S, Prado S, Grimes SR: Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. J Cell Biochem 2004;93:491-496.
48. Kubota N, Yano W, Yano W, Kubota T, Yamuchi T, Itoh S, Kumgari H, Kozono H, Takamoto I, Okomato S, Shiuchi T, Suzuki R, Satoh H, Tsuchida A, Moroi M, Sugi K, Noda T, Ebinuma H, Ueta Y, Kondo T, Araki E, Ezaki O, Nagai R, Tobe K, Terauchi Y, Ueki K, Minokoshi Y, Kadowaki T: Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 2007;6:3-4.
49. Park SH, Paulsen SR, Gammon SR, Mustard KJ, Hardie DG, Winder WW: Effects of thyroid state on AMP-activated protein kinase and acetyl-CoA carboxylase expression in muscle. J Appl Physiol 2002;93:2081-2088.